Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

697 public trials 122 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

NCT00004255

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +25 more
Locations
  • University of California San Diego Cancer Center La Jolla, California, United States
  • Presbyterian-St Luke's Medical Center Denver, Colorado, United States
  • Lombardi Cancer Center Washington D.C., District of Columbia, United States
  • Shands Hospital and Clinics, University of Florida Gainesville, Florida, United States
View all 15 locations
View Trial Details
Completed

Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome

NCT00003593

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Cancer Research Institute Mobile, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
View all 237 locations
View Trial Details
Completed

Decitabine in Treating Patients With Myelodysplastic Syndrome

NCT00003361

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +14 more
Locations
  • Johns Hopkins Oncology Center Baltimore, Maryland, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • University of Texas - MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

NCT00003619

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +36 more
Locations
  • Medical College of Pennsylvania Hospital Philadelphia, Pennsylvania, United States
  • Medical College of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions